Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Japan Mulls Importing Enough H1N1 Vaccine To Treat 20 Million

This article was originally published in PharmAsia News

Executive Summary

Japan might import enough H1N1 vaccines to treat as many as 20 million people in advance of epidemics that could break out in the fall or winter. The Health Ministry is trying to work out the proper number of doses, fearing it could need enough for 53 million if the government is to cover most elderly people. The ministry expects to make its decision by the end of July on how many of the elderly are to be given priority for vaccinations. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC072157

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel